Title: Senior Director, Research, Technology & Innovation, Biologics and Regenerative Medicine R&D
Company: Smith & Nephew Biotherapeutics
Location: Ft. Worth, Texas, United States
Dr. Nasreen Aboul-Ela Jacobson, Senior Director of Research, Technology, and Innovation at Smith & Nephew Biotherapeutics, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in medical research.
Since 2015, Dr. Nasreen Aboul-Ela Jacobson has been the Senior Director of Research, Technology, & Innovation for the biologics and regenerative medicine development division of Smith & Nephew Biotherapeutics. Dr. Jacobson’s work is focused on identifying and initiating the research process for potential new products for all of the company’s branches. When she began working with Smith & Nephew in 2013, Dr. Jacobson focused on development for the orthopedics and sports medicine divisions and took over product development for the regenerative medicine division when the branch was established.
Dr. Jacobson has enjoyed more than 30 years of experience in pharmaceutical research and began her career in 1992 as a senior scientist with Alcon Research, Ltd., where she remained until 2013. She holds a Master of Science in biochemistry from the University of Texas Graduate School of Biomedical Sciences and was awarded her Doctor of Philosophy in cell and molecular biology by the University of North Texas Health Science Center at Fort Worth in 2003. Dr. Jacobson discovered her passion for biochemistry during an undergraduate class and worked with the MD Anderson Cancer Center as a graduate student before joining the staff of a biochemical research laboratory, where she would spend the next seven years.
In recognition of her work, Dr. Jacobson was presented with a 2007 Top Scientist Award and a special R&D Scientist Award by Alcon Research, Ltd., and a 2021 Technical Excellence Award from Smith & Nephew Biotherapeutics. She is a member of the American Society for Cell Biology, the American Association for the Advancement of Science, and Sigma Xi.
Contact Dr. Jacobson:
